BACKGROUND: Recent experience with pandemic influenza A(H1N1)pdm09 highlighted the importance of global surveillance for severe respiratory disease to support pandemic preparedness and seasonal influenza control. Improved surveillance in the southern hemisphere is needed to provide critical data on influenza epidemiology, disease burden, circulating strains and effectiveness of influenza prevention and control measures. Hospital-based surveillance for severe acute respiratory infection (SARI) cases was established in New Zealand on 30 April 2012. The aims were to measure incidence, prevalence, risk factors, clinical spectrum and outcomes for SARI and associated influenza and other respiratory pathogen cases as well as to understand influenza contribution to patients not meeting SARI case definition. METHODS/ DESIGN: All inpatients with suspected respiratory infections who were admitted overnight to the study hospitals were screened daily. If a patient met the World Health Organization's SARI case definition, a respiratory specimen was tested for influenza and other respiratory pathogens. A case report form captured demographics, history of presenting illness, co-morbidities, disease course and outcome and risk factors. These data were supplemented from electronic clinical records and other linked data sources. DISCUSSION: Hospital-based SARI surveillance has been implemented and is fully functioning in New Zealand. Active, prospective, continuous, hospital-based SARI surveillance is useful in supporting pandemic preparedness for emerging influenza A(H7N9) virus infections and seasonal influenza prevention and control.
BACKGROUND: Recent experience with pandemic influenza A(H1N1)pdm09 highlighted the importance of global surveillance for severe respiratory disease to support pandemic preparedness and seasonal influenza control. Improved surveillance in the southern hemisphere is needed to provide critical data on influenza epidemiology, disease burden, circulating strains and effectiveness of influenza prevention and control measures. Hospital-based surveillance for severe acute respiratory infection (SARI) cases was established in New Zealand on 30 April 2012. The aims were to measure incidence, prevalence, risk factors, clinical spectrum and outcomes for SARI and associated influenza and other respiratory pathogen cases as well as to understand influenza contribution to patients not meeting SARI case definition. METHODS/ DESIGN: All inpatients with suspected respiratory infections who were admitted overnight to the study hospitals were screened daily. If a patient met the World Health Organization's SARI case definition, a respiratory specimen was tested for influenza and other respiratory pathogens. A case report form captured demographics, history of presenting illness, co-morbidities, disease course and outcome and risk factors. These data were supplemented from electronic clinical records and other linked data sources. DISCUSSION: Hospital-based SARI surveillance has been implemented and is fully functioning in New Zealand. Active, prospective, continuous, hospital-based SARI surveillance is useful in supporting pandemic preparedness for emerging influenza A(H7N9) virus infections and seasonal influenza prevention and control.
Authors: M G Baker; N Wilson; Q S Huang; S Paine; L Lopez; D Bandaranayake; M Tobias; K Mason; G F Mackereth; M Jacobs; C Thornley; S Roberts; C McArthur Journal: Euro Surveill Date: 2009-08-27
Authors: Cameron C Grant; Diane Emery; Tania Milne; Gregor Coster; Christopher B Forrest; Clare R Wall; Robert Scragg; Richard Aickin; Sue Crengle; Alison Leversha; Colin Tukuitonga; Elizabeth M Robinson Journal: J Paediatr Child Health Date: 2011-11-16 Impact factor: 1.954
Authors: Elektra Szewczuk; Kiran Thapa; Terry Anninos; Kenneth McPhie; Geoff Higgins; Dominic E Dwyer; Keith K Stanley; Jonathan R Iredell Journal: BMC Infect Dis Date: 2010-05-11 Impact factor: 3.090
Authors: Xiaoyan Lu; Brian Holloway; Ryan K Dare; Jane Kuypers; Shigeo Yagi; John V Williams; Caroline B Hall; Dean D Erdman Journal: J Clin Microbiol Date: 2007-12-05 Impact factor: 5.948
Authors: Justin R Ortiz; Viviana Sotomayor; Osvaldo C Uez; Otavio Oliva; Deborah Bettels; Margaret McCarron; Joseph S Bresee; Anthony W Mounts Journal: Emerg Infect Dis Date: 2009-08 Impact factor: 6.883
Authors: N Prasad; A A Trenholme; Q S Huang; M G Thompson; N Pierse; M A Widdowson; T Wood; R Seeds; S Taylor; C C Grant; E C Newbern Journal: Epidemiol Infect Date: 2018-07-26 Impact factor: 2.451
Authors: Emma Taylor; Kathryn Haven; Peter Reed; Ange Bissielo; Dave Harvey; Colin McArthur; Cameron Bringans; Simone Freundlich; R Joan H Ingram; David Perry; Francessa Wilson; David Milne; Lucy Modahl; Q Sue Huang; Diane Gross; Marc-Alain Widdowson; Cameron C Grant Journal: BMC Med Imaging Date: 2015-12-29 Impact factor: 1.930
Authors: Joan Puig-Barberà; Anita Tormos; Svetlana Trushakova; Anna Sominina; Maria Pisareva; Meral A Ciblak; Selim Badur; Hongjie Yu; Benjamin J Cowling; Elena Burtseva Journal: Influenza Other Respir Viruses Date: 2015-11 Impact factor: 4.380
Authors: Qiu Sue Huang; Nikki Turner; Michael G Baker; Deborah A Williamson; Conroy Wong; Richard Webby; Marc-Alain Widdowson Journal: Influenza Other Respir Viruses Date: 2015-07 Impact factor: 4.380
Authors: Karen A Alroy; Trang Thuy Do; Phu Dac Tran; Tan Quang Dang; Long Ngoc Vu; Nga Thi Hang Le; Anh Duc Dang; Nghia Duy Ngu; Tu Huy Ngo; Phuong Vu Mai Hoang; Lan Trong Phan; Thuong Vu Nguyen; Long Thanh Nguyen; Thinh Viet Nguyen; Mai Quang Vien; Huy Xuan Le; Anh The Dao; Trieu Bao Nguyen; Duoc Tho Pham; Van Thi Tuyet Nguyen; Thanh Ngoc Pham; Binh Hai Phan; Brett Whitaker; Thuy Thi Thu Do; Phuong Anh Dao; S Arunmozhi Balajee; Anthony W Mounts Journal: Influenza Other Respir Viruses Date: 2018-06-10 Impact factor: 4.380